Records containing: Prostate Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2011-06-27A Phase II, Randomised, Open-Label, Pilot Study to Evaluate the Safety and Effects on Bone Resorption of AZD0530 in Patients With Prostate Cancer or Breast Cancer With Metastatic Bone Disease.
-
CLINICAL_TRIALS study record update · 2011-06-23Phase1/2 Study of Vaccination With CDCA1 Derived Epitope Peptide for HLA-A24-positive Patients With Advanced Prostate Cancer
-
CLINICAL_TRIALS study record update · 2011-06-22The BIOPRES Trial; Transrectal BIOpsies of the PRostate: End Versus Side-firing
-
CLINICAL_TRIALS study record update · 2011-06-16A Phase II Trial of Two Doses of Conjugated Estrogens (Premarin) in Patients With Androgen-Independent Prostate Cancer
-
CLINICAL_TRIALS study record update · 2011-06-15A Randomised Phase II Study of Two Dose Schedules of PI-88 in Combination With Docetaxel in Patients With Androgen-independent Prostate Cancer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2011-06-08A Multicenter, Open-Label, Phase II Trial of Adjuvant Taxotere in Patients At High Risk of Relapse Following Prostatectomy
-
CLINICAL_TRIALS study record update · 2011-06-07A Phase II Study of Tandutinib (MLN518) in Androgen-Independent Prostate Cancer With Bone Metastases
-
CLINICAL_TRIALS study record update · 2011-05-30ClinicalTrials.gov study NCT00379782
-
CLINICAL_TRIALS study record update · 2011-05-24A Randomized, Double-blind, Multicentre, Phase II Controlled Trial Assessing ZACTIMATM (Vandetanib) Against Placebo in Prolonging the Off-treatment Interval in Prostate Cancer Subjects Undergoing Intermittent Androgen Deprivation Hormonal Therapy
-
CLINICAL_TRIALS study record update · 2011-05-24A Phase II, Double-blind, Placebo-controlled, Randomised Study to Assess the Efficacy and Safety of Docetaxel (Taxotere)/Prednisolone/ZD6474 vs Docetaxel/Prednisolone/Placebo in Patients With Hormone Refractory Prostrate Cancer (HRPC)
-
CLINICAL_TRIALS study record update · 2011-05-23Open-label, Multicenter,PhaseI Trial in Order To Determine the Safety and Pharmacokinetics of BAY43-9006 in Combination With Docetaxel as First-line Treatment in Metastatic Hormone Refractory Prostate Cancer Patients
-
CLINICAL_TRIALS study record update · 2011-05-18A Placebo-Controlled Study on the Effect of Epoetin Alfa in Patients With Malignancy Receiving Chemotherapy
-
CLINICAL_TRIALS study record update · 2011-05-16Phase 2 Randomized Study Evaluating 3 Chemotherapy Regimens as Second-line Treatment in Patients With Hormone-refractory Metastatic Prostate Cancer
-
CLINICAL_TRIALS study record update · 2011-05-16Phase 2 Trial of Maximum Androgen Blockade (MAB) Dose Escalation From 50 mg to 150 mg Bicalutamide (Casodex) for Biochemical Failure in Prostate Cancer Patients
-
CLINICAL_TRIALS study record update · 2011-05-10Phase I Study of Paclitaxel (Taxol) and Bortezomib (Velcade) in Patients With Refractory Solid Tumor Malignancies Involving an Activated MAPK Pathway
-
CLINICAL_TRIALS study record update · 2011-05-09A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
-
CLINICAL_TRIALS study record update · 2011-05-04A Randomized Trial of Tamsulosin and/or Dutasteride Versus Placebo to Relieve Urinary Symptoms After Brachytherapy for the Treatment of Localized Prostate Cancer
-
CLINICAL_TRIALS study record update · 2011-05-03Adjuvant Chemotherapy (Docetaxel and Estramustine Phosphate) for High Risk Localized Prostate Cancer
-
CLINICAL_TRIALS study record update · 2011-04-27Proof-of-Principle Trial of Communication to Patients Receiving Predictive Genetic Risk Assessment
-
CLINICAL_TRIALS study record update · 2011-04-13Osteoporosis Among Men Treated With Androgen Deprivation for Prostate Cancer: Symptoms, Risc Factors, and Prevention
-
CLINICAL_TRIALS study record update · 2011-03-30Evaluation of Radiation Therapy Positioning System (RTPS) in Patients With Localized Prostate Cancer
-
CLINICAL_TRIALS study record update · 2011-03-18The Rationale of the Study is to Demonstrate That Degarelix Given at Three-month Dosing Intervals Will Produce and Maintain Androgen Deprivation in Prostate Cancer Patients Through Immediate and Prolonged Testosterone Suppression, and to Provide Confirmatory Evidence of the Safety of Degarelix.
-
CLINICAL_TRIALS study record update · 2011-03-163D Recording of a Trans-rectal Prostate Biopsy
-
CLINICAL_TRIALS study record update · 2011-03-14Selenium and Prostate Cancer: Clinical Trial on Availability to Prostate Tissue and Effects on Gene Expression
-
CLINICAL_TRIALS study record update · 2011-03-09A Phase I/II, Open-Label, Dose Ranging Study of the Safety, Tolerance, Pharmacokinetics and Potential Activity of HE3235 When Administered Orally to Patients With Prostate Cancer